(2 mg + 0.05 mg + 4 mg)/ml, liquid for the skin
Prednisolone + Estradiol + Salicylic Acid
Alpicort E is a liquid for the skin, containing prednisolone, female sex hormones, and salicylic acid for use on the scalp.
Indications: in various forms of alopecia, especially androgen-dependent alopecia.
Before starting to use Alpicort E, you should discuss it with your doctor or pharmacist.
Alpicort E may only be used externally on the scalp due to its isopropyl alcohol content.
When treating for more than 2-3 weeks, due to the estrogen content in the solution, special precautions should be taken:
Protect your eyes and mucous membranes from contact with the preparation.
If the patient experiences blurred vision or other vision disturbances, they should contact their doctor.
Alpicort E may enhance the effects of other topically applied active substances due to its composition.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Pregnancy
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should consult your doctor or pharmacist before using this medicine.
During pregnancy, Alpicort E should not be used due to its salicylic acid content, except when used on small areas (less than 5 cm²).
Alpicort E should not be used due to its estrogen content.
If you become pregnant during treatment, you should stop using Alpicort E immediately. However, previous studies have not shown any effect on subsequent fertility.
During long-term treatment with glucocorticoids - a component of Alpicort E - during pregnancy, growth disturbances and harm to the unborn child cannot be excluded.
Breastfeeding
Your doctor should consider that prednisolone passes into breast milk.
The doctor will carefully assess whether it is necessary to use Alpicort E during breastfeeding. If long-term treatment is necessary, you should stop breastfeeding.
During breastfeeding, estrogens may change the amount and composition of breast milk. Small amounts of estrogens or their metabolites may pass into breast milk and affect the child. Glucocorticoids also pass into breast milk. Therefore, you should not breastfeed during treatment with Alpicort E, or you should only start treatment after the breastfeeding period has ended.
Alpicort E does not affect the ability to drive or use machines.
The medicine contains 50 mg of propylene glycol per 1 ml of solution (approximately equivalent to 180 mg of propylene glycol per single application). Propylene glycol may cause skin irritation.
This medicine should always be used exactly as your doctor has told you. If you are not sure, you should ask your doctor or pharmacist.
Alpicort E should always be used in accordance with the doctor's recommendations and the instructions in this leaflet. If you have any doubts, you should consult your doctor again.
Alpicort E is a solution for use on the skin.
If your doctor does not recommend otherwise, you should use Alpicort E once a day, preferably in the evening.
Once the inflammatory symptoms have improved, you can reduce the application to 2-3 times a week.
Each time you use the medicine, follow these steps:
The duration of treatment for small areas should not exceed 2-3 weeks due to the presence of prednisolone in the solution. Clinical experience includes treatment periods of up to 6 months. No studies have been conducted on the duration of action after discontinuation of the medicine.
If you use more than the recommended dose, you should contact your doctor or pharmacist immediately.
You should not take a double dose to make up for a missed dose.
You should continue treatment by taking the next scheduled dose at the usual time.
You should discuss further action with your doctor, as the effectiveness of the treatment may be compromised.
If you have any further doubts about using this medicine, you should consult your doctor or pharmacist.
Like all medicines, Alpicort E can cause side effects, although not everybody gets them.
Rarely(may affect up to 1 in 1,000 people): skin hypersensitivity (allergic contact dermatitis).
Very rarely(may affect up to 1 in 10,000 people): as with the use of any corticosteroid preparations, long-term use may lead to skin changes (reduction of skin thickness, widening of small blood vessels, formation of striae, steroid acne, perioral dermatitis, excessive body hair growth).
Unknown(frequency cannot be estimated from the available data): blurred vision.
Additionally, short-term skin irritations (e.g., burning, redness) are possible.
During long-term use in high doses or on large areas, as well as in cases of misuse, systemic corticosteroid effects are possible.
If you experience any side effects, including any side effects not listed in this leaflet, you should inform your doctor or pharmacist. You can report side effects directly to the Department for Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be kept out of the sight and reach of children.
Store in a temperature below 30°C. Store in the original packaging to protect from light.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste.
You should ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Alpicort E is a clear, colorless solution. The packaging contains a brown glass bottle with an applicator and a polypropylene closure, containing 100 ml of the medicine, and a leaflet.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Dr. August Wolff GmbH & Co. KG Arzneimittel
Sudbrackstrasse 56
33611 Bielefeld
Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
Sudbrackstrasse 56
33611 Bielefeld
Germany
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Bulgaria, the country of export:20011278
Parallel import authorization number:281/15
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.